BBSRC MIBTP Site directed mutagenesis, reverse genetics and complementation - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

BBSRC MIBTP Site directed mutagenesis, reverse genetics and complementation

Description:

BBSRC MIBTP Site directed mutagenesis, reverse genetics and complementation Chris Thomas, Joanne Hothersall, Yusra Al-Sammarraie, Mukul Yadav Biosciences, University ... – PowerPoint PPT presentation

Number of Views:167
Avg rating:3.0/5.0
Slides: 28
Provided by: www2Warw3
Category:

less

Transcript and Presenter's Notes

Title: BBSRC MIBTP Site directed mutagenesis, reverse genetics and complementation


1
BBSRC MIBTPSite directed mutagenesis, reverse
genetics and complementation
  • Chris Thomas, Joanne Hothersall, Yusra
    Al-Sammarraie, Mukul Yadav
  • Biosciences, University of Birmingham

2
Mutational analysis
  • Identification of gene responsible for a
    particular inherited trait
  • Identification of inherited trait associated with
    a particular gene
  • Identification of amino acids/nucleotides
    responsible for a particular property (promoter,
    operator, active site)
  • Determination of interactions between genes

3
Types of mutation
  • Point mutations/base substitutions
  • Deletions
  • Insertions
  • Frameshifts
  • Inversions
  • Translocations

4
Why reverse genetics?
  • Traditional genetics
  • Mutant phenotype gt Identification of a Gene
  • Reverse Genetics
  • Identification of a Gene gt Mutant phenotype

5
Complementation
  • Complete or partial restoration of a mutant
    phenotype to WT by provision of the WT gene
    elsewhere in the cell
  • Important to show that the defect observed is due
    to the gene identified rather than a defect in a
    different gene
  • Important to show that the defect observed is not
    due to a polar effect on down stream genes
  • Distinguish how many cistrons responsible for a
    particular phenotype

6
Making the mutation
  • Synthesise a mutant gene
  • Overlap extension and PCR

7
Making the mutation quick change
8
Knowing its there
PCR and sequencing PCR and restriction digest
WT
Mutant
Insertion of restriction site creates a
Restriction Fragment Length Polymorphism
9
Putting it back into the genome
10
  • K A Datsenko and B L Wanner (2000)
  • One-step inactivation of chromosomal genes in
    Escherichia coli K-12 using PCR products.
  • Proceedings of the National Academy of Sciences
    97, 66406645.

11
Datsenko and Wanner (2000)
  • Lambda Red recombinase needs gt35 nt arms
  • Linear fragment
  • AbR gene flanked by FLP recombinase targets

Gene X
12
Datsenko and Wanner (2000)
  • Advantages
  • Short synthetic arms
  • Selectable mutation
  • AbR easily deleted by FLP and Frt
  • Disadvantages
  • Requires linear DNA fragment to enter bacteria
  • Leaves a scar at the site of mutation
  • Secondary alterations in the chromosome due to
    lambda Red system

13
Gene Doctoring
  • As Datsenko Wanner but
  • DNA fragment generated in vivo by IsceI
    meganuclease
  • sacB gene used to select bacteria that have lost
    the donor plasmid
  • Lee DJ, Bingle LEH, Heurlier K, Pallen MJ, Penn
    CW, Busby SJW and Jon L Hobman JL (2009) Gene
    doctoring a method for recombineering in
    laboratory and pathogenic Escherichia coli
    strains. BMC Microbiology 9252

14
DNA fragment generated in vivo by IsceI
meganuclease
AbR
sacB
ISceI
x x
15
Forced integration and excision by homologous
recombination
  • Mutant cloned in suicide plasmid with sacB
  • Transfer to recipient bacteria selection
    isolates products of integration event
  • Purify integrants very carefully and check for
    sucrose sensitivity
  • Remove selection and allow excision
  • Isolate products of excision because they become
    resistant to sucrose

16
Suicide vector requires integration to establish
AbR
AbR
17
Suicide vector for non-enteric bacteria
18
Counter-selection
  • sacB encodes levan sucrase
  • Sucrase is extracellular in Gram ve bacteria
  • Levan accumulates in periplasm of Gram ves
  • This inhibits growth

glucose-fructose
glucose-fructose-glucose-fructosen
19
Other vectors for forcing integration
  • R6K oriV plasmids replicating in host providing
    Rep protein from the chromosome

oriV
rep
20
Other vectors for forcing integration
  • Non-mobilizable plasmid replicating in bacteria
    with conjugative plasmid select for transfer
    via cointegrate formation

Rare recombination
cointegrate
21
Construction of in-frame deletions
Construction of in-frame deletions
22
A. Kassem El-Sayed, Joanne Hothersall, Sian M.
Cooper, Elton Stephens, Thomas J. Simpson, and
Christopher M. Thomas (2003) Characterization of
the Mupirocin Biosynthesis Gene Cluster from
Pseudomonas fluorescens NCIMB 10586. Chemistry
Biology 10, 419430. Hothersall, J., Wu, J.,
Rahman, A.S., Shields, J.A, Haddock, J., Johnson,
N., Cooper, S.M., Stephens, E., Cox, R.J.,
Crosby, J., Willis, C.L., Simpson, T.J. and
Thomas, C.M. (2007). Mutational analysis reveals
that all tailoring region genes are required for
production of polyketide antibiotic mupirocin by
Pseudomonas fluorescens pseudomonic acid B
biosynthesis precedes pseudomonic acid A. J Biol
Chem 282, 15451-15461.
23
Design Exercise I
  • Aim to design primers to change one amino acid
    into another and create a restriction site change
    that can be used to detect the change in PCR
    products.

24
Designing the mutation
  • Overlap extension and PCR

25
Design Exercise I
  • You have been allocated one gene from the
    tailoring functions of the mupirocin biosynthetic
    cluster
  • Identify your assigned gene and copy the DNA
    sequence for the open reading frame plus at least
    500 bp upstream and downstream

26
Design Exercise I
  • Go to the protein sequence of the gene product at
    NCBI
  • Perform a blast search to find related proteins
  • Identify one or more highly conserved amino acids
    that may be essential for function of this and
    related proteins
  • Choose one amino acid that you will plan to
    mutate

27
Design Exercise I
  • Identify the DNA sequence corresponding to the
    amino acid that you have chosen. Change the
    triplet so that it will become an alanine or a
    different amino acid if you feel that you can
    argue for something else.
  • Examine the sequence overlapping the change to
    see if it causes a change in the restriction
    pattern.
  • If not then see if you can design further silent
    changes in the sequence so the restriction
    pattern does change.
Write a Comment
User Comments (0)
About PowerShow.com